Summary by Moomoo AI
Four Circles Pharmaceuticals filed its latest Securities Monthly Change Report on 31 January 2024 to report the latest changes in its shares and share options to Hong Kong Trading and Settlement Limited. The report shows that the regulated/registered share capital and issued shares of 4 Circle Pharmaceuticals remained unchanged in January 2024 at HK$1,000,000,000 and 9,329,999,206 shares. In addition, under the share option plan adopted on 24 October 2017, the Company currently has 74,110,000 share options outstanding and 7,500,000 share options unexercised at an exercise price of HK$0.972 and HK$2.22, respectively. The report does not mention any other changes in the shares concerned and confirms that all securities issuance has been approved by the Board and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.